Thus, in general, this resolved multitude might be the result of the multimodal muscleaxis impact
For subscriptions, we may retry the payment or suspend the subscription until payment is resolved
Currently, federal insurance programs cover Novo Nordisk's Wegovy -- one of the GLP-1s for people who are overweight and have heart disease -- but there is no medication for obesity alone covered by Medicare
Summary Patients with type 2 diabetes and cardiovascular disease should be started on either a GLP-1RA, SGLT-i, or both in high-risk cases, while simultaneously tapering any prescribed insulin regimen
This is the outcome least understood by patients
As this study was exploratory, there was no correction for multiple testing